The problem is that it is not easy to know what you are absorbing, or whether it will really change how you feel. At best, the CBD in America exists in a confused state of quasi-legality and potential to be realized. experts estimate that its market could rise to $ 22 billion by 2022, but since cannabis and hemp laws change rapidly from one country to another, the chemical is virtually unregulated on the market. consumption, and there is no labeling of finished products or compositional standards that allow buyers to understand what they are buying.

Misinformation reigns in the market, even when the CBD is sold as a relatively simple oil or supplement. When it is injected into a latte or into a cookie, the effects and effects of CBD become even more opaque. The strongest supporters of the substance make health claims well beyond current scientific evidence, and its most severe critics often dismiss the compound entirely as a simple snake oil in The long American tradition of health scams. Journalists are starts to have a handful what the CBD does and what we really know about it, but with researchers and regulators, we are still catching up with the people who pushed the complex to immediate success: entrepreneurs.

"Every day, I get an argument or two for new CBD products," says Rosemary Donahue. seduce editor-in-chief of the wellness magazine. Over the last few months, she has found that products are starting to switch from supplements to "beverages like coffee, seltzer and even chocolate." These products offer an easier entry point for the curious: you may not want to order a bottle of oil to the strange taste of a company you've never heard of online, but spend $ 3 for injecting CBD into your latte seems to be a relatively modest game. Even Coca-Cola is supposed to look into the CBD's beverage sector.

That these three dollars bring you something is a more complicated question. Esther Blessing, a researcher and professor of psychiatry at Langone Health at New York University, is one of the few researchers to have completed a study of the effects of CBD on mood. She has looked at her potential for treating anxiety and, although she points out the results, she is very preliminary. sees a lot of promises. "Until now, studies have shown that a specific dose of CBD is about as effective as drugs such as valium and other benzodiazepines to reduce experimental anxiety," she says.

But experimental anxiety, which involves applying stressors to make a volunteer anxious to be tested, is different from clinical anxiety, and rigorous and long-term clinical trials are needed to determine the true effects of CBD. on the patients. Several are ongoing at the present time, including an ongoing blessing at NYU, but the process to complete them, find the appropriate dosages and create a consistent drug that can meet the Food Approval Standards. and Drug Administration takes time. "The FDA approval process is going on in eight or ten years," said Blessing.